Skip to content
StockMarketAgent
Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

IDX/IRRA stock hub

IDX/IRRA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

IDX/IRRAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
769B
Indonesia Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
IDX/IRRA
In the news

Latest news · IDX/IRRA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.4P50 14.4P75 23.9
Trailing P/E11.9
P25 11.5P50 23.8P75 52.6
ROE11.9
P25 0.6P50 5.1P75 12.2
ROIC6.7
P25 1.3P50 6P75 11.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All IDX/IRRA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
205
Groups with data
11
Currency
IDR
Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Indonesia
Country code
ID
Employees
117
Employees Change
0%
Employees Change Percent
0
Enterprise value
IDR 1.6T
Exchange
Indonesia Stock Exchange
Financial currency
IDR
First seen
2026-05-10
Industry
Medical Distribution
Isin
ID1000151707
Last refreshed
2026-05-10
Market cap
IDR 769B
Price
IDR 510
Price currency
IDR
Rev Per Employee
9,427,240,668.68x
Sector
Healthcare
Sic
5047
Symbol
idx/IRRA
Website
https://www.itama.co.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
8.57%
EV Earnings
24.95x
EV/EBIT
14.54x
EV/EBITDA
12.66x
EV/FCF
-4.43x
EV/Sales
1.49x
FCF yield
-48.26%
P/B ratio
1.31x
P/E ratio
11.95x
P/S ratio
0.7x
PE Ratio10 Y
63.51x
PE Ratio3 Y
102.92x
PE Ratio5 Y
73.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
10.19%
EBITDA Margin
11.71%
Gross margin
24.36%
Gross Profit
IDR 268.7B
Gross Profit Growth
17.35%
Gross Profit Growth Q
21.82%
Gross Profit Growth3 Y
25.99%
Gross Profit Growth5 Y
11.92%
Net Income
IDR 65.9B
Net Income Growth
11.2%
Net Income Growth Q
3.63%
Net Income Growth Years
2%
Net Income Growth3 Y
25.74%
Net Income Growth5 Y
-3.61%
Pretax Margin
7.17%
Profit Margin
5.97%
Profit Per Employee
IDR 563.3M
Profitable Years
10
ROA
3.12
Roa5y
5.91
ROCE
8.54
ROE
11.86
Roe5y
12.79
ROIC
6.7
Roic5y
16.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr1y
21.45%
Cagr3y
-14.81%
Cagr5y
-20.7%
EPS Growth
8.6
EPS Growth Q
3.66
EPS Growth Years
2
EPS Growth3 Y
27.06
EPS Growth5 Y
-4.06
Revenue Growth
3.08x
Revenue Growth Q
1.16x
Revenue Growth Years
2x
Revenue Growth3 Y
23.84x
Revenue Growth5 Y
7.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
IDR 0.49
Assets
IDR 2.6T
Cash
IDR 110.4B
Current Assets
IDR 1.7T
Current Liabilities
IDR 1.2T
Debt
IDR 986B
Debt EBITDA
IDR 7.63
Debt Equity
IDR 1.68
Debt FCF
IDR -2.66
Equity
IDR 588.5B
Interest Coverage
3
Liabilities
IDR 2T
Long Term Assets
IDR 812.2B
Long Term Liabilities
IDR 727.6B
Net Cash
IDR -875.6B
Net Cash By Market Cap
IDR -114
Net Debt EBITDA
IDR 6.78
Net Debt Equity
IDR 1.49
Tangible Book Value
IDR 588.5B
Tangible Book Value Per Share
IDR 368
WACC
4.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.41
Inventory Turnover
1.3
Net Working Capital
IDR 1.1T
Quick ratio
0.57
Working Capital
IDR 503.9B
Working Capital Turnover
IDR 2.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-2.4%
Dividend per share
IDR 0
Last Dividend
IDR 18.75

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
21.43%
200-day SMA
422.5
3Y total return
-38.18%
50-day SMA
397.6
50-day SMA vs 200-day SMA
50under200
5Y total return
-68.63%
All Time High
4,390
All Time High Change
-88.38%
All Time High Date
2021-01-13
All Time Low
350
All Time Low Change
45.71%
All Time Low Date
2019-11-18
ATR
18.45
Beta
0.36
Beta1y
0.97
Beta2y
0.65
Ch YTD
20.28
High
510
High52
545
High52 Date
2025-06-02
High52ch
-6.42%
Low
410
Low52
352
Low52 Date
2026-01-29
Low52ch
44.89%
Ma50ch
28.27%
Price vs 200-day SMA
20.7%
RSI
86.77
RSI Monthly
52.22
RSI Weekly
71.67
Sharpe ratio
0.7x
Sortino ratio
1.69
Total Return
-2.4%
Tr YTD
20.28
Tr1m
30.77%
Tr1w
31.44%
Tr3m
26.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
IDR 112.4B
Operating Income Growth
16.09
Operating Income Growth Q
89.12
Operating Income Growth3 Y
27.32
Operating Income Growth5 Y
1.61
Operating margin
10.19

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
204,161,600%
Net Borrowing
250,893,279,234
Shares Insiders
0.01%
Shares Out
1,507,817,400
Shares Qo Q
-8.78%
Shares Yo Y
2.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
IDR -371.1B
Average Volume
3,569,700x
Bv Per Share
367.8
CAPEX
IDR -44.2B
Ch1m
30.77
Ch1w
31.44
Ch1y
21.43
Ch3m
26.24
Ch3y
-38.18
Ch5y
-69.09
Ch6m
13.84
Change
25%
Change From Open
24.39
Close
408
Days Gap
0.49
Depreciation Amortization
16,787,164,376
Dollar Volume
27,119,556,000
Earnings Date
2026-08-05
EBIT
IDR 112.4B
EBITDA
IDR 129.2B
EPS
IDR 42.68
F Score
4
FCF
IDR -371.1B
FCF EV Yield
-22.57x
FCF Per Share
IDR -246
Financing CF
250,893,279,234
Fiscal Year End
December
Founded
1,988
Graham Number
594.32968
Graham Upside
16.54
Income Tax
IDR 13.1B
Investing CF
-33,398,850,359
Is Primary Listing
1
Last Earnings Date
2025-10-31
Last Report Date
2026-03-31
Lynch Fair Value
IDR 213
Lynch Upside
-58.16
Ma150
421.5
Ma150ch
20.98%
Ma20
401.5
Ma20ch
27.02%
Net CF
-119,946,962,728
Next Earnings Date
2026-08-05
Open
410
Position In Range
100
Ppne
97,983,494,505
Price Date
2026-05-08
Price EBITDA
IDR 5.95
Ptbv Ratio
1.31
Relative Volume
18.53x
Revenue
1,102,987,158,235x
Tax By Revenue
1.19x
Tax Rate
16.62%
Tr6m
13.84%
Volume
53,175,600
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does IDX/IRRA pay a dividend?

Capital-return profile for this ticker.

Performance

IDX/IRRA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+21.4%
S&P 500 1Y: n/a
3Y total return
-38.2%
S&P 500 3Y: n/a
5Y total return
-68.6%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns IDX/IRRA?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+0.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+2.4%
Negative means the company is buying back shares.
Technical

IDX/IRRA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
86.8
Above 70: short-term overbought
Price vs 200-day MA
+20.7%
50/200-day relationship not available
Beta (5Y)
0.36
Less volatile than the market
Sharpe ratio
0.70
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About IDX/IRRA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/IRRA stock rating?

idx/IRRA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/IRRA analysis?

The full report lives at /stocks/idx/IRRA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/IRRA?

The latest report frames idx/IRRA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/IRRA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.